[HTML][HTML] Capturing the conversion of the pathogenic alpha-1-antitrypsin fold by ATF6 enhanced proteostasis

S Sun, C Wang, P Zhao, GM Kline, JMD Grandjean… - Cell chemical …, 2023 - cell.com
Genetic variation in alpha-1 antitrypsin (AAT) causes AAT deficiency (AATD) through liver
aggregation-associated gain-of-toxic pathology and/or insufficient AAT activity in the lung …

[HTML][HTML] Leveraging population genomics for individualized correction of the hallmarks of alpha-1 antitrypsin deficiency

C Wang, P Zhao, J Teckman… - … Diseases: Journal of the …, 2020 - ncbi.nlm.nih.gov
Deep medicine is rapidly moving towards a high-definition approach for therapeutic
management of the patient as an individual given the rapid progress of genome sequencing …

[HTML][HTML] Tracing genetic diversity captures the molecular basis of misfolding disease

P Zhao, C Wang, S Sun, X Wang, WE Balch - Nature Communications, 2024 - nature.com
Genetic variation in human populations can result in the misfolding and aggregation of
proteins, giving rise to systemic and neurodegenerative diseases that require management …

Profiling genetic diversity reveals the molecular basis for balancing function with misfolding in alpha-1 antitrypsin

C Wang, P Zhao, S Sun, X Wang, WE Balch - bioRxiv, 2022 - biorxiv.org
Genetic variation of alpha-1 antitrypsin (AAT) is responsible for alpha-1-antitrypsin
deficiency (AATD) leading to gain-of-toxic aggregation in the liver and loss-of-function on n …

[图书][B] Measuring the effect of histone deacetylase inhibitors (HDACi) on the secretion and activity of alpha-1 antitrypsin

C Wang, M Bouchecareilh, WE Balch - 2017 - Springer
Abstract Alpha-1 antitrypsin deficiency (AATD) is a protein conformational disease with the
most common cause being the Z-variant mutation in alpha-1 antitrypsin (Z-AAT). The …

Gaussian Process Captures the Conversion of the Pathogenic Alpha-1-Antitrypsin Fold by ATF6 Enhanced Proteostasis

S Sun, C Wang, P Zhao, G Kline… - Available at SSRN …, 2022 - papers.ssrn.com
Genetic variation in alpha-1 antitrypsin (AAT) causes AAT deficiency (AATD) through liver
aggregation-associated gain-of-toxic pathology and/or insufficient AAT activity in the lung …